methylenetetrahydrofolate reductase polymorphisms in iranian patients with glanzmann’s thrombasthenia

Authors

shima kazemzadeh department of laboratory hematology and blood banking, faculty of allied medicine, kerman university of medical sciences

rezvan mohammadi pathology and stem cell research center, kerman university of medical sciences, kerman, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی کرمان (kerman university of medical sciences)

fatemeh shadkam farokhi pathology and stem cell research center, kerman university of medical sciences, kerman, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی کرمان (kerman university of medical sciences)

alireza shafiian school of veterinary medicine, shahid bahonar university of kerman, kerman, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی کرمان (kerman university of medical sciences)

abstract

background: the most common polymorphisms identified in the methylenetetrahydrofolate reductase (mthfr) gene, c677t and a1298c lead to defective activity of this enzyme and increase the risk of venous and arterial thrombosis. there are limited investigations regarding the effects of thrombogenic polymorphisms on the clinical phenotypes of rare hereditary hemorrhagic disorders like glanzmann's thrombasthenia (gt) and the exact correlation between mthfr polymorphisms and gt is not well established. this calls for further studies in populations with a large number of such patients. so, this study was performed to question whether coinheritance of mthfr polymorphisms and gt can modulate the clinical phenotype of gt. material and methods: in the present case-control study which performed at pathology and stem cell research center at kerman university of medical sciences, 65 patients with gt and 100 normal voluntary blood donors as the control group were evaluated. the mean (sd) age of patients and the control group were 2.33±1.54 years (range 0-5 years) and 2.6±1.72, respectively. the detection of mthfr c677t and a1298c polymorphisms was carried out using a polymerase chain reaction- restriction fragment length polymorphism (pcr-rflp) method. in accord with the glanzmann's thrombasthenia italian team (glatit) protocol, the clinical severity of bleeding in patients with gt was determined. two tests of descriptive statistics (i.e. frequencies) and chi-square, using the spss version 19, were employed to analyze the data. results: based on results, there were no significant statistical differences in the prevalence of the mthfr c677t polymorphism (p=0.703) or the mthfr a1298c polymorphism (p=0.187) between patients and the control group. in addition, no association between the severity of bleeding and these polymorphisms was found (p=0.385). conclusions: it was concluded that the thrombogenic mutations of mthfr do not solely modulate the severity of clinical symptoms in patients with gt

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Methylenetetrahydrofolate Reductase Polymorphisms in Iranian Patients with Glanzmann’s Thrombasthenia

Background: The most common polymorphisms identified in the Methylenetetrahydrofolate reductase (MTHFR) gene, C677T and A1298C lead to defective activity of this enzyme and increase the risk of venous and arterial thrombosis. There are limited investigations regarding the effects of thrombogenic polymorphisms on the clinical phenotypes of rare hereditary hemorrhagic disorders like Glanzmann's t...

full text

Methylenetetrahydrofolate reductase gene polymorphisms in patients with nonalcoholic steatohepatitis (NASH).

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of abnormal hepatic steatosis in the absence of a history of alcohol use. Nonalcoholic steatohepatitis (NASH) is the progressive form of NAFLD. Hyperhomocysteinemia causes steatosis, and the methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms result in hyperhomocysteinemia. To examine whether the C677T and ...

full text

Methylenetetrahydrofolate reductase gene polymorphisms in patients with schizophrenia.

To investigate the role of methylenetetrahydrofolate reductase gene polymorphisms in schizophrenia, we analyzed the genotypes of MTHFR677 and MTHFR1298 of 130 schizophrenic patients and 226 controls, using a polymerase chain reaction restriction fragment length polymorphism method. The MTHFR T677 allele was significantly distributed (chi(2)=7.900; P=0.019), between schizophrenic cases and healt...

full text

Methylenetetrahydrofolate reductase polymorphisms in myeloid leukemia patients from Northeastern Brazil

Methylenetetrahydrofolate reductase (MTHFR: EC 1.5.1.20) polymorphisms are associated to acute lymphoid leukemia in different populations. We used the polymerase chain reaction and the restriction fragment length polymorphism method (PCR-RFLP) to investigate MTHFR C677T and A1298C polymorphism frequencies in 67 patients with chronic myeloid leukemia (CML), 27 with acute myeloid leukemia FAB sub...

full text

Methylenetetrahydrofolate reductase gene polymorphisms in Egyptian Turner Syndrome patients.

BACKGROUND Folate metabolism dysfunctions can result in DNA hypomethylation and abnormal chromosome segregation. Two common polymorphisms of the methylenetetrahydrofolate reductase (MTHFR) encoding gene (C677T and A1298C) reduce MTHFR activity, but when associated with aneuploidy, the results are conflicting. Turner Syndrome (TS) is an interesting model for investigating the association between...

full text

Methylenetetrahydrofolate reductase gene polymorphisms in Burkina Faso.

In Burkina Faso, the levels of plasma homocysteine (Hcy) are lower and the methionine loading tests suggest a more effective Hcy metabolism [1,2]. We found a relevant difference in the allele frequencies of C677T: T 7.7% in the young and 3.3% in old subjects respectively (see Table 1). Frequencies of C677T genotypes in old and young individuals were in Hardy Weinberg equilibrium (HWE). The diff...

full text

My Resources

Save resource for easier access later


Journal title:
iranian journal of pediatric hematology and oncology

جلد ۷، شماره ۱، صفحات ۴۸-۵۶

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023